glp-1 drug market competition 2025 Weight Loss Size, Share Outlook for obesity in 2025:

Doi: 18

The risk of vomiting, dehydration, and electrolyte imbalances climbs sharply

Slower, more mindful eating is thought to have benefits related to GLP-1 too

However, both medications have been shown to be safe and effective tools for weight management when used under medical supervision

The interaction of obesityrelated hormones, adipocytokines, and inflammatory cytokines is hypothesized to stimulate antiapoptotic genes and impact cell migration, proliferation, and angiogenesis in a prooncogenic fashion [25, 26]

While GLP-1 receptor agonists (such as semaglutide and liraglutide) have demonstrated significant benefits in diabetes management, weight reduction, and cardiovascular outcomes in clinical trials, enhancing physiological GLP-1 through dietary and lifestyle modifications represents a foundational approach